The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance

AH Balen, LC Morley, M Misso, S Franks… - Human reproduction …, 2016 - academic.oup.com
BACKGROUND Here we describe the consensus guideline methodology, summarise the
evidence-based recommendations we provided to the World Health Organisation (WHO) for …

GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type

CB Lambalk, FR Banga, JA Huirne… - Human reproduction …, 2017 - academic.oup.com
BACKGROUND Most reviews of IVF ovarian stimulation protocols have insufficiently
accounted for various patient populations, such as ovulatory women, women with polycystic …

Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice

A La Marca, SK Sunkara - Human reproduction update, 2014 - academic.oup.com
BACKGROUND The main objective of individualization of treatment in IVF is to offer every
single woman the best treatment tailored to her own unique characteristics, thus maximizing …

[HTML][HTML] Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline

S Pfeifer, S Butts, D Dumesic, G Fossum, C Gracia… - Fertility and sterility, 2016 - Elsevier
Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a
guideline - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books …

Gonadotrophin‐releasing hormone antagonists for assisted reproductive technology

HG Al‐Inany, MA Youssef, RO Ayeleke… - Cochrane Database …, 2016 - cochranelibrary.com
Background Gonadotrophin‐releasing hormone (GnRH) antagonists can be used to prevent
a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without …

A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF

T Sha, X Wang, W Cheng, Y Yan - Reproductive biomedicine online, 2019 - Elsevier
This meta-analysis aimed to study whether pregnancy-related outcomes and complications
differed between patients with polycystic ovary syndrome (PCOS) and those with other …

Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta …

S Kadoura, M Alhalabi, AH Nattouf - Scientific reports, 2022 - nature.com
Gonadotropin-releasing hormone (GnRH) analogues are commonly used in clinical practice
to prevent premature luteinizing hormone (LH) surge during In-Vitro Fertilization/Intra …

Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles

M Toftager, J Bogstad, T Bryndorf, K Løssl… - Human …, 2016 - academic.oup.com
STUDY QUESTION Is the risk of severe ovarian hyperstimulation syndrome (OHSS) similar
in a short GnRH antagonist and long GnRH agonist protocol in first cycle IVF/ICSI patients …

Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention

CO Nastri, DM Teixeira, RM Moroni… - … in Obstetrics & …, 2015 - Wiley Online Library
Objective To identify, appraise and summarize the current evidence regarding the
pathophysiology, staging, prediction and prevention of ovarian hyperstimulation syndrome …

Oxidative stress in granulosa cells contributes to poor oocyte quality and IVF-ET outcomes in women with polycystic ovary syndrome

Q Lai, W Xiang, Q Li, H Zhang, Y Li, G Zhu, C Xiong… - Frontiers of …, 2018 - Springer
The increased levels of intracellular reactive oxygen species (ROS) in granulosa cells (GCs)
may affect the pregnancy results in women with polycystic ovary syndrome (PCOS). In this …